CAM
TEVA icon

ClariVest Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

ClariVest Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$9.76M Hold
600,816
– – 1% 11
2024
Q2 		$9.76M Buy
600,816
+9,816
+2% +$151K 1% 11
2024
Q1 		$8.34M Buy
591,000
+198,700
+51% +$2.5M 0.86% 13
2023
Q4 		$4.1M Sell
392,300
-7,600
-2% -$71K 0.23% 78
2023
Q3 		$4.08M Buy
399,900
+1,400
+0.4% +$13K 0.22% 79
2023
Q2 		$3M Sell
398,500
-9,600
-2% -$77.8K 0.15% 97
2023
Q1 		$3.61M Sell
408,100
-7,300
-2% -$72.2K 0.16% 114
2022
Q4 		$3.79M Sell
415,400
-16,100
-4% -$140K 0.18% 103
2022
Q3 		$3.48M Buy
431,500
+33,000
+8% +$292K 0.17% 108
2022
Q2 		$3M Sell
398,500
-12,100
-3% -$105K 0.13% 136
2022
Q1 		$3.86M Buy
410,600
+313,100
+321% +$2.61M 0.15% 138
2021
Q4 		$782K Buy
97,500
+9,100
+10% +$82.1K 0.02% 370
2021
Q3 		$861K Buy
88,400
+1,000
+1% +$9.36K 0.03% 344
2021
Q2 		$865K Sell
87,400
-4,600
-5% -$48.7K 0.03% 319
2021
Q1 		$1.06M Sell
92,000
-3,600
-4% -$41.3K 0.04% 278
2020
Q4 		$923K Sell
95,600
-300
-0.3% -$2.87K 0.03% 282
2020
Q3 		$864K Buy
95,900
+17,600
+22% +$186K 0.03% 315
2020
Q2 		$966K Buy
78,300
+26,350
+51% +$298K 0.03% 326
2020
Q1 		$467K Buy
+51,950
New +$532K 0.01% 405
2019
Q2 		– Sell
-9,818
Closed -$154K – 748
2019
Q1 		$154K Sell
9,818
-300
-3% -$5.29K ﹤0.01% 526
2018
Q4 		$156K Sell
10,118
-1,482
-13% -$30.4K ﹤0.01% 569
2018
Q3 		$251K Buy
+11,600
New +$269K ﹤0.01% 560

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

ClariVest Asset Management's TEVA Position: Q3 2024 in Review

ClariVest Asset Management held its Teva Pharmaceuticals (TEVA) position steady in Q3 2024 at 600,816 shares worth $9.76M. The position accounts for 1% of the portfolio, ranked #11.

ClariVest Asset Management first reported a position in TEVA in Q3 2018 and has held it in 22 quarters since. 543 funds tracked by Wall St. Rank hold TEVA as of Q3 2024.

  • ClariVest Asset Management held 600,816 shares of Teva Pharmaceuticals worth $9.76M as of Q3 2024.
  • ClariVest Asset Management left its Teva Pharmaceuticals share count unchanged in Q3 2024.
  • Teva Pharmaceuticals made up 1% of ClariVest Asset Management's portfolio in Q3 2024, its #11 holding.
  • ClariVest Asset Management first reported a position in Teva Pharmaceuticals in Q3 2018 and has held it in 22 quarters since.
  • 543 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2024.

Based on ClariVest Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.